Science Explorer Back to mapMap
Discussion
Company · Lexington · United States

Synta Pharmaceuticals (United States)

ROR OpenAlex
World rank, all time
#29,517
of 34,923
Rank in United States
#6,205
of 7,310
Research works
161
◆ 1% vs 2018-21
Citations
5.5k
34.1 per fractional work
Top-10% rate
20.9%
all institutions 10.0%
vs its own fields
1.08×
1.00× is exactly expected
Open access
33%
world 40%
International
18%
world 18%
Synta Pharmaceuticals (United States)

Which fields of science does Synta Pharmaceuticals (United States) work in?

In 2022-now, 71% of research at Synta Pharmaceuticals (United States) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (9%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 71.5% of its workMedicine: 16 fractional works · 71.2% of its workHematology: 3 fractional works · 14.0% of its workOncology: 3 fractional works · 11.4% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 10.7% of its workSurgery: 1 fractional works · 5.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 4.2% of its workNeurology: 1 fractional works · 3.4% of its workGenetics: 1 fractional works · 3.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.0% of its workDermatology: 0 fractional works · 1.9% of its workImmunology and Allergy: 0 fractional works · 1.8% of its workEpidemiology: 0 fractional works · 1.6% of its workEmergency Medicine: 0 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.9% of its workGastroenterology: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.6% of its workHepatology: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workInternal Medicine: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workLife Sciences: 6 fractional works · 24.7% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 15.7% of its workMolecular Biology: 2 fractional works · 10.7% of its workCancer Research: 1 fractional works · 3.1% of its workGenetics: 0 fractional works · 1.3% of its workBiotechnology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 2 fractional works · 9.0% of its workImmunology: 2 fractional works · 9.0% of its workPhysical Sciences: 1 fractional works · 2.9% of its workEngineering: 0 fractional works · 1.4% of its workComputational Mechanics: 0 fractional works · 0.7% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workPhysics and Astronomy: 0 fractional works · 0.7% of its workStatistical and Nonlinear Physics: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 0.9% of its workSocial Sciences: 0 fractional works · 0.5% of its workSociology and Political Science: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKSyntaPharmaceuticals…23fractional works, 2022-now
Life Sciences25%Physical Sciences3%Health Sciences71%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine1671.2%
    2. Nursing00.3%
    1. Biochemistry, Genetics and Molecular Biology415.7%
    2. Immunology and Microbiology29.0%
    1. Engineering01.4%
    2. Physics and Astronomy00.7%
    3. Chemistry00.7%
    1. Social Sciences00.5%
    2. Economics, Econometrics and Finance00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.94× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 8.99× its world share, 2 worksImmunology and Micro…Chemistry: 0.44× its world share, 0 worksChemistryEngineering: 0.10× its world share, 0 worksEngineeringPhysics and Astronomy: 0.33× its world share, 0 worksPhysics and AstronomyMedicine: 3.70× its world share, 16 worksMedicineNursing: 0.50× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.20× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.0×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Immunology and Microbiology8.99×2 works
  2. Medicine3.70×16 works
  3. Biochemistry, Genetics and Molecular Biology2.94×4 works
  4. Nursing0.50×0 works
  5. Chemistry0.44×0 works
  6. Physics and Astronomy0.33×0 works
  7. Economics, Econometrics and Finance0.20×0 works
  8. Engineering0.10×0 works
  9. Social Sciences0.04×0 works

Who are the top researchers at Synta Pharmaceuticals (United States)?

Ranked on the quality score, Richard C. Bates, Ronald K. Blackman and Iman A. El‐Hariry lead among researchers whose main affiliation is Synta Pharmaceuticals (United States).

  1. 1 Richard C. Bates United States · #197,574 worldwide 5.2k citations · 141 works
  2. 2 Ronald K. Blackman United States · #221,507 worldwide 5.5k citations · 58 works
  3. 3 Iman A. El‐Hariry United States · #256,107 worldwide 3.8k citations · 113 works
  4. 4 David A. Proia United States · #333,016 worldwide 4.4k citations · 259 works
  5. 5 Gerard M. McGeehan United States · #343,029 worldwide 6.2k citations · 106 works
  6. 6 Jim Sang United States · #528,780 worldwide 1.7k citations · 166 works
  7. 7 Eric W. Jacobson United States · #590,705 worldwide 2.9k citations · 47 works
  8. 8 Suqin He United States · #610,996 worldwide 2.4k citations · 36 works
  9. 9 Takayo Inoue United States · #644,937 worldwide 1.7k citations · 101 works
  10. 10 Vojo Vukovic United States · #729,370 worldwide 1.1k citations · 24 works
All ranked researchers at Synta Pharmaceuticals (United States)

What are the most cited papers from Synta Pharmaceuticals (United States)?

The most cited paper from Synta Pharmaceuticals (United States) is "A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium" (Zhenqiang Su et al., 2014), with 1,092 citations. Next come "The NLR Gene Family: A Standard Nomenclature" (984) and "Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region" (894).

Most cited papers
#PaperReleasedCitations
1 A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium Zhenqiang Su et al. · Nature Biotechnology Open access161 authors 21 Aug 2014 1,092
2 The NLR Gene Family: A Standard Nomenclature Jenny P.‐Y. Ting et al. · Immunity Open access Mar 2008 984
3 Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region Hisham Mohamed Mehanna, T.J. Beech, Tom Nicholson et al. · Head & Neck Review 20 Jan 2012 894
4 Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors Vinit Kumar et al. · Cancer Cell Open access Nov 2017 670
5 The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia Ghayas C. Issa et al. · Nature Open access 15 Mar 2023 501
All 60 most cited papers, with filters and sorting

Which keywords describe research at Synta Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Echocardiography, Cancer Therapy, Constrictive Pericarditis, Pericarditis, Monoclonal Antibodies, Mutation, Immunotherapy and Regulation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Echocardiography2▲ 36×2 topics
  2. Cancer Therapy2▲ 16×6 topics
  3. Constrictive Pericarditis2▲ 469×1 topic
  4. Pericarditis2▲ 469×1 topic
  5. Cancer2▲ 5.3×9 topics
  6. Epidemiology2▲ 1.81×15 topics
  7. Inflammation2▲ 3.1×11 topics
  8. Monoclonal Antibodies2▲ 74×3 topics
  9. Mutation2▲ 35×2 topics
  10. Diagnosis1▲ 6.4×13 topics
  11. Immunotherapy1▲ 8.7×7 topics
  12. Regulation1▲ 12×3 topics
  13. Therapeutic Antibodies1▲ 79×2 topics
  14. Hematopoietic Stem Cells1▲ 60×3 topics
  15. Glycosylation1▲ 43×2 topics
  16. Prognostic Factors1▲ 11×4 topics
  17. Cell Cycle1▲ 127×1 topic
  18. p531▲ 193×1 topic

Which research topics does Synta Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Pericarditis and Cardiac Tamponade, Cancer-related Molecular Pathways, Monoclonal and Polyclonal Antibodies Research and Myasthenia Gravis and Thymoma.

Pericarditis and Cardiac…2Pericarditis and Cardiac Tamponade: 2 fractional worksCancer-related Molecular Pathways: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksMyasthenia Gravis and Thymoma: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksAcute Myeloid Leukemia Research: 1 fractional worksHemophilia Treatment and…1Hemophilia Treatment and Research: 1 fractional worksMultiple Myeloma Research and Treatments: 1 fractional worksIntraperitoneal and Appendiceal Malignancies: 0 fractional worksCardiac tumors and thrombi: 0 fractional works
Cardiology and Cardiovascular MedicineOncologyRadiology, Nuclear Medicine and ImagingNeurology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pericarditis and Cardiac Tamponade Cardiology and Cardiovascular Medicine 2 works
  2. 2 Cancer-related Molecular Pathways Oncology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Myasthenia Gravis and Thymoma Neurology 1 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 1 works
  6. 6 Acute Myeloid Leukemia Research Hematology 1 works
  7. 7 Hemophilia Treatment and Research Hematology 1 works
  8. 8 Multiple Myeloma Research and Treatments Hematology 1 works
  9. 9 Intraperitoneal and Appendiceal Malignancies Surgery 0 works
  10. 10 Cardiac tumors and thrombi Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.6%not open67.4%

World: 40% of research is openly available.

with international co-authors17.9%domestic only82.1%

World: 18% is written across borders.

How has Synta Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 1% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Synta Pharmaceuticals (United States) as a percentage of every work published that year, 0.000088% in 2024.

still counting0.00020%0.00040%0.00060%Synta Pharmaceuticals (United States)0.000086% in 20251990200020102020

Fractional works of Synta Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lexington

All research institutions in Lexington

Share Synta Pharmaceuticals (United States)'s ranking

Synta Pharmaceuticals (United States) on Science Explorer

A card with Synta Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Synta Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.